[1]
Giustolisi, R., Fantozzi, N., Staltari, M., Marchiori, J., Mastrangelo, O., Marcucci, R., Mirra, F., Mazzotta, P., Gabrieli, C.B. and The Luce Study Group 2011. Combined intravitreal ranibizumab and verteporfin photodynamic therapy versus ranibizumab alone for the treatment of age-related macular degeneration. Digital Journal of Ophthalmology. 17, 3 (Sep. 2011), 23–30. DOI:https://doi.org/10.5693/djo.01.2011.05.003.